A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
SpringWorks Therapeutics, Inc.
InSilico Medicine Hong Kong Limited
Verismo Therapeutics
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Numab Therapeutics AG
Oncovir, Inc.
Ascentage Pharma Group Inc.
Checkpoint Therapeutics, Inc.
BerGenBio ASA
Suzhou Maximum Bio-tech Co., Ltd.
Ikena Oncology
UTC Therapeutics Inc.
Prelude Therapeutics
Multitude Therapeutics Inc.
Seagen Inc.
Bayer
Mabpro, a.s.
Quadriga Biosciences, Inc.
Eli Lilly and Company
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Novartis
Aduro Biotech, Inc.
Incyte Corporation
Verastem, Inc.